<DOC>
	<DOCNO>NCT02262676</DOCNO>
	<brief_summary>Depict demographic clinical feature patient atrial fibrillation treat rivaroxaban prevent stroke pulmonary embolism routine clinical practice</brief_summary>
	<brief_title>Observational Study Assess Sociodemographic Clinical Features Patients Treated With Rivaroxaban Routine Clinical Practice Hematologists , Cardiologists Internists Spain</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Patients â‰¥ 18 year Patients atrial fibrillation Patients treatment rivaroxaban stroke prevention atrial fibrillation least 3 month previous inclusion period study Patients treatment start study Patients treat anticoagulant treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Stroke prevention Atrial Fibrillation</keyword>
	<keyword>Prevention Control</keyword>
	<keyword>Stroke</keyword>
</DOC>